Trials / Unknown
UnknownNCT04295785
Juvenile Autoimmune Necrotizing Myopathies
Clinical, Paraclinical, Functional Characteristics and Evolution of Juvenile Autoimmune Necrotizing Myopathies in a National Retrospective Cohort
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 10 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Autoimmune necrotizing myopathies (AINM) in adult patients are characterized by severity of muscle damage, presence of necrosis with little inflammation on muscle biopsy and anti-HMGCR or anti-SRP auto-antibodies. Data on AINM in children are currently lacking. The purpose of this study is to specify the characteristics at AINM diagnosis, treatments and evolution of juvenile AINM with anti-HMGCR or anti-SRP antibodies.
Conditions
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2020-11-01
- Completion
- 2020-11-01
- First posted
- 2020-03-05
- Last updated
- 2020-03-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04295785. Inclusion in this directory is not an endorsement.